Festival of Biologics

Join us in Basel, Switzerland, for the 2024 Festival of Biologics.

The Festival of Biologics is the opportunity to hear from industry leaders, global regulators and world-renowned academics at the forefront of innovation. Get ready for 3 days of cutting-edge insights into the latest industry developments.

NEW TRACKS FOR 2024

The Festival of Biologics brings you the latest developments across the entire value chain of the biologics industry, and is always looking to bring new content each year to deliver on this. In 2024, we are proud to introduce and expand on the following sessions.

DIAGNOSTICS

Diagnostic devices, technologies and approaches are a vital part of the drug development cycle, with different versions being used at all stages, from discovery through development to clinical trials. This year, a dedicated Companion Diagnostics track will explore advances in matching patients to therapeutics, examining personalized medicine, biomarker analysis and in vivo diagnostic techniques. Elsewhere on the agenda, speakers will present on diagnostic devices, including wearables in clinical trials, the characterization of early-stage therapeutic proteins, and the implementation of molecular diagnostics for pharmacogenomics.

TRANSLATIONAL MEDICINE

The Festival of Biologics aims to cover the start-to-finish of the biologics value chain and, therefore, is excited to introduce a key link in the chain between engineering therapeutics and clinical development: translational medicine. Presentations will explore strategies for moving from lab development to the clinic, introducing clinical practice, and considerations for benchside, bedside and community engagement.

LATE STAGE DEVELOPMENT AND COMMERCIALISATION

Building on our story of the start-to-finish, the Festival of Biologics brings you a revamped session on delivering therapies to market. With sessions exploring the European regulatory landscape, market access and sustainability, and the impact of real-world evidence and pricing on commercialization, as well as the impact of biosimilars and the lessons that can be learnt from these therapies, this full three-day track is designed both for experts in these areas and for those who want to develop their understanding of this final stage before launch.

PCI will be exhibiting at this event and available to discuss your biotech and pharma needs

For more information or to register for this event, please see the event website